Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been making waves in the healthcare sector with its groundbreaking treatments for ...

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

New York, New York-- (Newsfile Corp. - January 29, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel.Invest with Confidence: Follow ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

On Wednesday, the judge agreed to hold hearings to consider both requests. By Corey Kilgannon The former New Jersey senator was sentenced to 11 years in prison after being convicted of bribery and ...

While the Oscar nominations are bringing attention back to last year’s slate of films, the new year promises a new schedule of movies for cinephiles to keep an eye out for. From awards season ...

Is Said to Discuss Dropping Case Against Eric Adams Officials under President Trump talked with Manhattan prosecutors about possibly abandoning the corruption case against the mayor of New York City.